Introduction
Melatonin is one of the most widely used nutraceutical ingredients for supporting sleep–wake cycles and overall sleep quality. It is commonly applied in sleep management, stress support, and healthy aging formulations.
However, conventional melatonin formulations are often characterized by rapid release, which may limit duration of action and reduce coverage throughout the sleep cycle.
In this context, MINIACTIVES® technology, developed by IPS, enables a functional microencapsulation approach designed for prolonged release, while also offering dosage flexibility and multi-dose applications.
Properties and application fields of melatonin
Melatonin is an endogenous hormone with key functions in the regulation of circadian rhythm:
- Sleep–wake cycle regulation
It contributes to the synchronization of biological rhythms. - Support for sleep quality
Used in nutritional protocols to promote sleep onset and sleep maintenance. - Management of stress and altered rhythms
Applied in situations such as jet lag, shift work, and chronic stress. - Healthy aging
Included in formulations dedicated to general well-being and the maintenance of physiological balance.
Formulation challenges
- rapid release with short duration of action
- difficulty maintaining stable levels overnight
- need for adaptable dosing strategies
- limited flexibility in traditional formulations
IPS innovation: Melatonin MINIACTIVES®
Melatonin MINIACTIVES® is produced using proprietary MINIACTIVES® technology, designed to modulate release and improve formulation management.
Key benefits include:
- prolonged release for extended sleep support
- dosage flexibility
- multi-dose formulation capability
- improved uniformity of active distribution
Scientific evidence
The benefits of MINIACTIVES® technology are supported by clinical studies conducted on Coenzyme Q10 and Citicoline MINIACTIVES®, demonstrating improved release profile, bioaccessibility, and tolerability.
These results confirm that the observed benefits are attributable to the MINIACTIVES® technology itself.
Conclusion
With Melatonin MINIACTIVES®, IPS provides a solution enabling prolonged release, flexible dosing, and multi-dose applications, improving the overall effectiveness of sleep-support nutraceuticals.
MINIACTIVES® confirms SURACTIVES® by IPS as a technology provider in advanced nutraceutical design.
Note: This article is provided for informational purposes only and does not substitute professional medical advice.
